Halozyme Therapeutics, Inc.【HALO】 経常(税引前)利益率(%)の推移

機能の使い方
(単位:%) 経常(税引前)利益率(%) 前年比(%)
4Q25 -22.3 -137.3%
3Q25 61.8 +8.6%
2Q25 62.9 +23.6%
1Q25 54.3 +10.8%
4Q24 59.8 +36.0%
3Q24 56.9 +20.9%
2Q24 50.9 +20.8%
1Q24 49.0 +52.2%
4Q23 44.0 +12.8%
3Q23 47.1 +33.6%
2Q23 42.1 +114.0%
1Q23 32.2 -49.2%
4Q22 39.0 -27.4%
3Q22 35.3 -44.9%
2Q22 19.7 -70.6%
1Q22 63.4 +101.1%
4Q21 53.7 -10.7%
3Q21 64.0 +15.2%
2Q21 67.1 +43.1%
1Q21 31.5 -231.3%
4Q20 60.2 -193.7%
3Q20 55.5 -202.7%
2Q20 46.9 -225.6%
1Q20 -24.0 -852.7%
4Q19 -64.2 +2038.0%
3Q19 -54.1 -50.4%
2Q19 -37.3 -42.5%
1Q19 3.2 -103.6%
4Q18 -3.0 -104.7%
3Q18 -109.0 -2186.3%
2Q18 -64.9 -28.3%
1Q18 -88.3 -20.1%
4Q17 64.1 -220.4%
3Q17 5.2 -106.0%
2Q17 -90.6 +13.7%
1Q17 -110.5 -
4Q16 -53.2 -
3Q16 -86.8 -
2Q16 -79.7 -